BAGGER RICHARD H

SEC Form 4 insider trading activity

BAGGER RICHARD H has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 24, 2026.

On the most recent filing, BAGGER RICHARD H is listed as Director at Tonix Pharmaceuticals Holding Corp. Inside the rolling window, BAGGER RICHARD H reported 1 open-market purchase totaling $13K in TNXP and no open-market sales.

Companies traded

Other insiders at TNXP

Insider Buying

$13K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
TNXPPurchase$13KAug 24SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has BAGGER RICHARD H made?

BAGGER RICHARD H has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does BAGGER RICHARD H trade?

BAGGER RICHARD H has filed SEC Form 4 disclosures for 1 company, including TNXP.

When was BAGGER RICHARD H's most recent SEC Form 4 filing?

BAGGER RICHARD H's most recent SEC Form 4 filing on Tracefour is dated Aug 24, 2026.

What is BAGGER RICHARD H's total buy and sell value in the current window?

Inside the rolling retention window, BAGGER RICHARD H bought $13K and sold $0 based on SEC Form 4 filings.

What was BAGGER RICHARD H's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 1,000 TNXP shares on 2026-08-20, worth $13K, per SEC Form 4 filings.